arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Sotera Health Co

SHC

$18.87 ▼ -0.02 (-0.11%) at close

7 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

Sotera Health Co demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $5.4B

Dividend Yield —

Revenue Growth 5.7% ↗

Op. Margin None

ROIC None

FCF / Share $0.53 ↗

Trailing P/E 69.9x

Price / Book 8.8x

FCF Yield 2.8%

Debt / Equity 3.53

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.16B

↑ +5.7% —

Net Income Profit after all expenses

$77.95M

↑ +75.6% —

Operating Margin Operating profit as % of sales

27.0%

↑ +2.6% —

FCF / Share Free cash flow per share

$0.53

↑ +229.4% —

Long-Term Debt Long-term obligations

$2.14B

↓ -3.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	5.7% Fair → Fair Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-28%)	4.9% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-39%)	4.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-43%)	7.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	13.9% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+73%)	5.1% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-36%)	—
EPS Growth YoY (%)	68.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-11.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	-77.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—
Net Income Growth YoY (%)	75.6% Excellent Excellent Year-over-year change in net income	-13.6% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-85.2% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	229.4% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	-46.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	127.6% Excellent Excellent Year-over-year change in free cash flow	-28.5% Weak Weak Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	5.1% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	5.7% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	8.6% Fair Fair Compound annual revenue growth over 3 years	8.8% Fair Fair Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	7.3% Fair Fair Compound annual revenue growth over 5 years	7.2% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—
EPS CAGR 3Y (%)	—	-26.9% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	27.0% Excellent → Excellent Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+80%)	26.4% Excellent → Excellent Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+76%)	24.7% Good → Good Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+65%)	27.6% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+84%)	25.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	23.6% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+57%)
Effective Tax Rate (%) (%)	47.2% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	61.0% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	51.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	33.3% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2129.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	6.7% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-44%)	4.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-66%)	4.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-59%)	-23.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-294%)	12.5% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-4.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-139%)	-2.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-122%)
FCF Margin (%) (%)	12.8% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-34.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	9.5% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	19.3% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	8.2% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	11.8% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	1.91x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-7.06x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.41x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.53x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.74x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-4.40x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	—	4.4% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.0% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	8.7% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	—	9.7% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	8.8% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	8.0% Fair → Fair Stable Operating profit relative to total assets Optimal: > 10%	9.2% Fair Fair Operating profit relative to total assets Optimal: > 10%	7.5% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	12.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	11.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	11.6% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-23%)	-66.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-545%)	19.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+33%)	-8.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	3.53x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+489%)	5.49x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+815%)	5.02x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+737%)	5.55x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+825%)	2.97x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+396%)	4.03x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+572%)	—
Interest Coverage (x)	—	1.65x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	1.59x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	3.27x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	4.37x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	0.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	1.22x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$1.80B	$1.95B	$1.93B	$1.55B	$1.64B	$1.72B	—
Debt / EBITDA (x)	—	5.82x Weak → Weak Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.31x Weak → Weak Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.22x Weak → Weak Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	5.43x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	6.78x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$4.10	$3.89	$3.73	$3.58	$3.34	$3.44	$3.35
Basic EPS, GAAP (USD)	$0.27	$0.16	$0.18	$-0.83	$0.41	$-0.16	$-0.09
Free Cash Flow per Share (USD)	$0.53	$0.16	$-1.29	$0.34	$0.64	$0.28	$0.39
Book Value per Share (USD)	$2.13	$1.43	$1.58	$1.25	$2.10	$1.95	—
Tangible Book Value per Share (USD)	$-2.77	$-3.51	$-3.86	$-4.44	$-4.06	$-5.62	—
Basic Weighted Avg Shares (shares)	283.96M	282.78M	281.01M	280.10M	279.23M	237.70M	232.40M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$363.83M	$335.04M	$326.59M	$-146.56M	$184.80M	$174.42M	—
LT Debt (USD)	$2.14B	$2.22B	$2.23B	$1.94B	$1.74B	$1.82B	—
Total Equity (USD)	$606.03M	$404.91M	$443.73M	$350.24M	$586.10M	$452.30M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$1.16B	$1.10B	$1.05B	$1.00B	$931.48M	$818.16M	$778.33M
Depreciation Expense (USD)	$94.90M	$84.30M	$76.60M	$64.30M	$64.20M	$63.30M	$66.70M
Net Income, GAAP (USD)	$77.95M	$44.40M	$51.38M	$-233.57M	$116.88M	$-38.62M	$-20.85M
Operating Cash Flow (USD)	$287.19M	$224.16M	$-147.73M	$277.96M	$281.55M	$120.58M	$149.04M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Sotera Health Co

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SHC with peers